ArticleData in brief2025
A dataset for splenomegaly and its related findings in CT imaging.
Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Splenomegaly, defined as an abnormal enlargement of the spleen, is a critical radiological finding associated with a spectrum of serious health conditions, particularly liver disorders and hematologic malignancies. While Computed Tomography (CT) scans are commonly utilized in clinical settings to detect and assess the severity of splenomegaly, recent studies have demonstrated its potential to reveal new insights into the underlying causes of splenomegaly, such as liver cirrhosis and lymphoma, when integrated with machine and deep learning models. This enables patients to receive timely and appropriate treatment, thereby reducing the risk of complications. However, research in this area remains in its early stages, primarily due to the limited availability of real-world datasets required to develop and train robust Artificial Intelligence (AI)-based models. This article introduces a diverse dataset specifically curated for the study of splenomegaly and its associated findings. Collected at King Abdullah University Hospital in northern Jordan, the dataset includes 248 de-identified CT scans and patient data from 248 adult subjects (42% female), with a mean age of 48.2 years (ranging from 18 to 91 years). It encompasses cases both with and without splenomegaly, covering a range of diseases such as liver cirrhosis, lymphoma, leukemia, myeloproliferative neoplasms, and thalassemia. This work presents an open-access dataset dedicated to splenomegaly, aiming to address the lack of publicly available resources in this area. Furthermore, it supports the development of AI-driven diagnostic models for detecting splenomegaly, evaluating its severity, and identifying its potential causes. Additionally, it serves as an educational resource for medical students studying splenomegaly. The dataset is freely accessible via the Zenodo data repository, providing a valuable foundation for further research and advancements in diagnostic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.